Carole J. Spangler
Corporate Officer/Principal bei Clario Medical Imaging, Inc.
Aktive Positionen von Carole J. Spangler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Clario Medical Imaging, Inc.
 Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Carole J. Spangler
Ehemalige bekannte Positionen von Carole J. Spangler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DENDREON CORPORATION | Corporate Officer/Principal | - | - |
Ausbildung von Carole J. Spangler
| The Johns Hopkins University | Doctorate Degree |
| University of Washington | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Clario Medical Imaging, Inc.
Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Carole J. Spangler
- Erfahrung
